Literature DB >> 31574564

Randomized controlled trial comparing hydroxychloroquine with pioglitazone as third-line agents in type 2 diabetic patients failing metformin plus a sulfonylurea: A pilot study.

Stanley H Hsia1, Petra Duran1, Martin L Lee1, Mayer B Davidson1.   

Abstract

Entities:  

Keywords:  anti-inflammation; hydroxychloroquine; insulin sensitivity; pioglitazone

Mesh：

Substances：

Year:  2019        PMID： 31574564     DOI： 10.1111/1753-0407.12989

Source DB:  PubMed          Journal:  J Diabetes        ISSN： 1753-0407            Impact factor:   4.006


× No keyword cloud information.
  8 in total

Review 1.  Diabetes-Modifying Antirheumatic Drugs: The Roles of DMARDs as Glucose-Lowering Agents.

Authors:  Marco Infante; Nathalia Padilla; Rodolfo Alejandro; Massimiliano Caprio; David Della-Morte; Andrea Fabbri; Camillo Ricordi
Journal:  Medicina (Kaunas)       Date:  2022-04-21       Impact factor: 2.948

2.  Effect of hydroxychloroquine on glucose control in patients with and without diabetes: a systematic review and meta-analysis of randomized controlled clinical trials.

Authors:  Luis E Simental-Mendía; Mario Simental-Mendía; Adriana Sánchez-García; Enrique Linden-Torres
Journal:  Eur J Clin Pharmacol       Date:  2021-05-19       Impact factor: 2.953

3.  Mechanism of higher risk for COVID-19 in diabetes: a mask to lift.

Authors:  Chen Fang; Yun Huang; Heming Guo; Yihui Sun; Hui Li; Xuna Bian; Haixia Guan; Ji Hu
Journal:  Endocrine       Date:  2020-07-23       Impact factor: 3.633

4.  Efficacy and safety of hydroxychloroquine for managing glycemia in type-2 diabetes: A systematic review and meta-analysis.

Authors:  D Dutta; R Jindal; D Mehta; M Kumar; M Sharma
Journal:  J Postgrad Med       Date:  2022 Apr-Jun       Impact factor: 1.566

Review 5.  Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic.

Authors:  Marco Infante; Camillo Ricordi; Andrea Fabbri
Journal:  J Diabetes       Date:  2020-06-11       Impact factor: 4.530

Review 6.  The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment.

Authors:  Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2020       Impact factor: 1.990

Review 7.  Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates.

Authors:  Durga Prasanna Misra; Armen Yuri Gasparyan; Olena Zimba
Journal:  Rheumatol Int       Date:  2020-09-02       Impact factor: 2.631

Review 8.  Repurposing New Use for Old Drug Chloroquine against Metabolic Syndrome: A Review on Animal and Human Evidence.

Authors:  Sok Kuan Wong
Journal:  Int J Med Sci       Date:  2021-05-13       Impact factor: 3.738
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.